Literature DB >> 8849220

Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities.

S Sreevatsan1, X Pan, K E Stockbauer, D L Williams, B N Kreiswirth, J M Musser.   

Abstract

Two genes (rpsL and rrs) with mutations associated with streptomycin resistance in Mycobacterium tuberculosis were characterized in 78 streptomycin-resistant and 61 streptomycin-susceptible isolates recovered from patients living in the United States, South America, Europe, Africa, and Asia. Fifty-four percent of the 78 resistant organisms had missense mutations in codon 43 of rpsL resulting in a K-43-->R substitution. Mutations in codon 88 of rpsL were also identified in four Asian isolates.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8849220      PMCID: PMC163252     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  A ribosomal gene mutation in streptomycin-resistant Mycobacterium tuberculosis isolates.

Authors:  J Douglass; L M Steyn
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

2.  Ribosomal proteins. 33. Location of amino-acid replacements in protein S12 isolated from Escherichia coli mutants resistant to streptomycin.

Authors:  G Funatsu; H G Wittmann
Journal:  J Mol Biol       Date:  1972-07-28       Impact factor: 5.469

3.  Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance.

Authors:  A Meier; P Kirschner; F C Bange; U Vogel; E C Böttger
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

4.  Mutations in ribosomal proteins S4 and S12 influence the higher order structure of 16 S ribosomal RNA.

Authors:  P N Allen; H F Noller
Journal:  J Mol Biol       Date:  1989-08-05       Impact factor: 5.469

Review 5.  Antimicrobial agent resistance in mycobacteria: molecular genetic insights.

Authors:  J M Musser
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

6.  Streptomycin resistance in mycobacteria.

Authors:  N Honoré; S T Cole
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

7.  Nationwide survey of drug-resistant tuberculosis in the United States.

Authors:  A B Bloch; G M Cauthen; I M Onorato; K G Dansbury; G D Kelly; C R Driver; D E Snider
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

8.  Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot.

Authors:  M Finken; P Kirschner; A Meier; A Wrede; E C Böttger
Journal:  Mol Microbiol       Date:  1993-09       Impact factor: 3.501

9.  Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study.

Authors:  B Heym; N Honoré; C Truffot-Pernot; A Banerjee; C Schurra; W R Jacobs; J D van Embden; J H Grosset; S T Cole
Journal:  Lancet       Date:  1994-07-30       Impact factor: 79.321

10.  Mutations in 16S ribosomal RNA disrupt antibiotic--RNA interactions.

Authors:  E A De Stasio; D Moazed; H F Noller; A E Dahlberg
Journal:  EMBO J       Date:  1989-04       Impact factor: 11.598

View more
  47 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Fitness cost of chromosomal drug resistance-conferring mutations.

Authors:  Peter Sander; Burkhard Springer; Therdsak Prammananan; Antje Sturmfels; Martin Kappler; Michel Pletschette; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

Review 3.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

4.  Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.

Authors:  Florence Brossier; Nicolas Veziris; Alexandra Aubry; Vincent Jarlier; Wladimir Sougakoff
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

5.  Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism.

Authors:  Fernanda S Spies; Pedro E Almeida da Silva; Marta O Ribeiro; Maria Lucia Rossetti; Arnaldo Zaha
Journal:  Antimicrob Agents Chemother       Date:  2008-06-09       Impact factor: 5.191

Review 6.  Genetic methods for assessing antimicrobial resistance.

Authors:  F R Cockerill
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

7.  Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide capreomycin antibiotics in Korea.

Authors:  Hum Nath Jnawali; Heekyung Yoo; Sungweon Ryoo; Kwang-Jun Lee; Bum-Joon Kim; Won-Jung Koh; Chang-Ki Kim; Hee-Jin Kim; Young Kil Park
Journal:  World J Microbiol Biotechnol       Date:  2013-01-18       Impact factor: 3.312

8.  Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis.

Authors:  Annika Krüüner; Pontus Jureen; Klavdia Levina; Solomon Ghebremichael; Sven Hoffner
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

9.  Activation and transfer of the chromosomal phage resistance mechanism AbiV in Lactococcus lactis.

Authors:  Jakob Haaber; Sylvain Moineau; Karin Hammer
Journal:  Appl Environ Microbiol       Date:  2009-03-13       Impact factor: 4.792

10.  Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa.

Authors:  Thomas R Ioerger; Sunwoo Koo; Eun-Gyu No; Xiaohua Chen; Michelle H Larsen; William R Jacobs; Manormoney Pillay; A Willem Sturm; James C Sacchettini
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.